TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| 6 Ways to Trade FDA and Clinical Trial News Mike Havrilla submits:Beyond the strategy of selecting a basket of small/micro-cap stocks with pending binary events such as FDA decisions and clinical trial results, another means of achieving diversification is by selecting a basket of companies with different types of pending catalysts. Below are some examples of how to categorize pending bio-catalyst events and some specific examples for each category.Bio Run-Up StrategyThis is a common strategy used by many investors is to buy a basket of several small or micro-cap companies (generally less than $1 billion market cap stocks) with pending binary events (e.g. FDA decision or clinical trial results) approximately 3-6 months ahead of the expected catalyst date and sell into the expected upward momentum in both stock price and trading volume.Complete Story » seekingalpha.com |
Illumina’s 2Q Earnings Report: A Cheat Sheet Wall Street Cheat Sheet submits: By Elliot TurnerYesterday after the bell, Illumina (ILMN), a leader in genome analysis and sequencing, and a recent Tech Cheat Sheet focus stock, reported a blockbuster quarter: EPS checked in at $0.26/share against estimates of $0.23/share on revenues of $212 million, comfortably above the $194 million estimate. For the 2010 fiscal year, management projects earnings per share of $0.93-$1.00, raising the bottom line of their estimate, and revenues of $852 million against the previously projected $825 million.Complete Story » seekingalpha.com |
Renewable Energy Stocks Fuel IPO Queue The Burrill Report submits: By Marie DaghlianPetroAlgae (PALG) and Gevo (GEVO), two alternative fuel and chemical companies, hope to fire up the tepid IPO waters. PetroAlgae, which produces biocrude from duckweed, has not generated any revenue yet, and has just filed to go public. The Florida-based renewable energy company, which has traded over the counter under an inactive shell corporation, hopes to raise $200 million. The underwriters of the offering are Goldman Sachs; UBS Investment Bank, and Citi. Complete Story » seekingalpha.com |
Alere Health Executives and Clients Share Insights in How to Enroll and Engage Participants in Health and Wellness Programs [PR Newswire] - Sharing best-in-class strategies on how to enroll and engage employees and health plan members in health and wellness programs will be the key focus of a panel discussion featuring clients of Alere Health at the Care Continuum Alliance's Forum 10 & Integrated Care Summit, held October 13 – 15 in Washington, D.C.  Alere client leaders from The Procter & Gamble Company and Scripps Health will share their experiences and strategies for enrollment and engagement during the panel discussion scheduled for Thursday, October 14, 1:45 to 2:45 p.m. us.rd.yahoo.com |
Matrixx Initiatives CEO Discusses F2Q2011 Results - Earnings Call Transcript Matrixx Initiatives, Inc. (MTXX)F2Q2011 Earnings Conference CallOctober 26, 2010 11 AM ETComplete Story » seekingalpha.com |